Pot stocks really out of favour. I see that Tilray reported this...

Pot stocks really out of favour. I see that Tilray reported this week and went backwards bigtime. Knock on effect to all MM stocks. MDC not immune as the drift continues, remember its only phase 2 trail but importantly for a market that is crying for alternatives to opiates and Fentanyl.
Was there a small hint of the trial being good in the Observational Study announcement = "Medlab is currently developing a protocols for a Phase 3 trial to be used in Australia and USA. "